Androgens as anabolic agents for bone

Trends in Endocrinology and Metabolism

Volumn 7, Issue 3, 1996, Pages 77-84

  Orwoll, Eric S ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANABOLIC AGENT; ANDROGEN; ANDROGEN RECEPTOR; CALCIUM; ESTROGEN; GESTAGEN; GONADORELIN; NANDROLONE; NORETHISTERONE; STANOZOLOL; TESTOSTERONE;

AGING; BONE DENSITY; BONE GROWTH; BONE MINERAL; CALCIUM METABOLISM; CLINICAL TRIAL; DELAYED PUBERTY; FEMALE; FRACTURE; HORMONE DEFICIENCY; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; ORCHIECTOMY; OSTEOPOROSIS; OVARIECTOMY; POSTMENOPAUSE; PRIORITY JOURNAL; REVIEW;

EID: 0029978894     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/1043-2760(96)00024-0     Document Type: Article

References (56)

1. Aerssens J, et al.: 1993. Mechanical properties, bone mineral content, and bone composition (collagen, osteocalcin, IGF-1) of the rat femur: influence of ovariectomy and nandrolone decanoate (anabolic steroid) treatment. Calcif Tissue Int 53:269-277.
2. Arisaka O, Arisaka M: 1991. Effect of testosterone on radial bone mineral density in adolescent male hypogonadism. Acta Paediatr Scand 80:378-380.
3. Baran DT, et al.: 1978. Effect of testosterone therapy on bone formation in an osteoporotic hypogonadal male. Calcif Tissue Res 26:103-106.
4. Beck T, et al.: 1992. Sex differences in geometry of the femoral neck with aging: a structural analysis of bone mineral data. Calcif Tissue Int 50:24-29.
5. Bellido T, et al.: 1995. Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. J Clin Invest 95:2886-2895.
6. Birkenhager JC, et al.: 1992. Can nandrolone add to the effect of hormonal replacement therapy in postmenopausal osteoporosis? Bone Miner 18:251-265.
7. Bonjour J-P, et al.: 1991. Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence. J Clin Endocrinol Metab 73:555-563.
8. Buchanan JR, et al.: 1988a. Effect of excess endogenous androgens on bone density in young women. J Clin Endocrinol Metab 67: 937-943.
9. Buchanan JR, et al.: 1988b. Determinants of peak trabecular bone density in women: the role of androgens, estrogen, and exercise. J Bone Miner Res 3:673-680.
10. Chesnut CHI, et al: 1983. Stanozolol in post-menopausal osteoporosis: therapeutic efficacy and possible mechanisms of action. Metabolism 32:571-580.
11. Clarke BL, et al.: 1993. Increased bone turn-over with aging in men is not due to test-osterone deficiency [abst]. In Proceedings of the Annual Meeting of the Endocrine Society, Las Vegas, NV. Bethesda, MD: The Endocrine Society.
12. Colvard DS, et al.: 1989. Identification of androgen receptors in normal human osteoblast-like cells. Proc Natl Acad Sci USA 86: 854-857.
13. Davis SR, et al.: 1995. Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality. Maturitas 21:227-236.
14. Delmas P, Meunier PJ: 1981. L'ostéoporose au cours du syndrome de Klinefelter: données histologiques osséuses quantitatives dans cinq cas: relation avec la carence hormonale. Nouv Presse Med 10:687.
15. Diamond T, et al.: 1991. Effects of testosterone and venesection on spinal and peripheral bone mineral in six hypogonadal men with hemochromatosis. J Bone Miner Res 6:39-43.
16. Dixon JE, et al.: 1989. Bone mass in hirsute women with androgen excess. Clin Endocrinol 30:271-277.
17. Finkelstein JS, et al.: 1989. Increases in bone density during treatment of men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 69:776-783.
18. Finkelstein JS, et al.: 1987. Osteoporosis in men with idiopathic hypogonadotropic hypogonadism. Ann Int Med 106:354-361.
19. Finkelstein JS, et al.: 1992. Osteopenia in men with a history of delayed puberty. N Engl J Med 326:600-604.
20. Francis RM, Peacock M: 1986. Osteoporosis in hypogonadal men: role of decreased plasma 1,25-dihydroxyvitamin D, calcium malabsorption, and low bone formation. Bone 7:261-268.
21. Garn SM, et al.: 1992. Continuing bone expansion and increasing bone loss over a two-decade period in men and women from a total community sample. Am J Hum Biol 4:57-67.
22. Gilsanz V, et al.: 1993. Gender differences in vertebral dimensions in children and adolescents. Radiology 190:673-677.
23. 6-GnRH). J Clin Endocrinol Metab 76:288-290.
24. Goulding A, Gold E: 1993. Flutamide-mediated androgen blockade evokes osteopenia in the female rat. J Bone Miner Res 8:763-769.
25. Gunness M, Orwoll ES: 1995. Early induction of alterations in cancellous and cortical bone histology after orchiectomy in mature rats. J Bone Miner Res (in press).
26. Hannan MT, et al.: 1992. Bone mineral density in elderly men and women: results from the Framingham osteoporosis study. J Bone Miner Res 7:547-553.
27. Horowitz M, et al.: 1992. Osteoporosis and Kleinefelter's syndrome. Clin Endocrinol (Oxf) 36:113-118.
28. Jackson and Kleerekoper: 1987.
29. Johansen JS, et al.: 1989. Treatment of post-menopausal osteoporosis: is the anabolic steroid nandrolone decanoate a candidate? Bone Miner 6:77-86.
30. Kasra M, Grynpas MD: 1995. The effects of androgens on the mechanical properties of primate bone. Bone 17:265-270.
31. Kelly PJ, et al.: 1990. Dietary calcium, sex hormones, and bone mineral density in men. Br Med J 300:1361-1364.
32. Lyritis GP, et al.: 1994. Effect of nandrolone decanoate and 1-α-hydroxycalciferol on patients with vertebral osteoporotic collapse: a double-blind clinical trial. Bone Miner 27:209-217.
33. Martin B: 1993. Aging and strength of bone as a structural material. Calcif Tissue Int 53: S34-S40.
34. Mauras N, et al.: 1994. Calcium and protein kinetics in prepubertal boys. J Clin Invest 93:1014-1019.
35. Melton LJI, Cummings SR: 1987. Heterogeneity of age-related fractures: implications for epidemiology. J Bone Miner Res 2:321-331.
36. Morishima A, et al.: 1995. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab 80:3689-3698.
37. Mosekilde L: 1989. Sex differences in age-related loss of vertebral trabecular bone mass and structure: biomechanical consequences. Bone 10:425-432.
38. Murphy S, et al.: 1993. Sex hormones and bone mineral density in elderly men. Bone Miner 20:133-140.
39. Need AG, et al.: 1986. Comparison of calcium, calcitriol, ovarian hormones and nandrolone in the treatment of osteoporosis. Maturitas 8:275-280.
40. Need AG, et al.: 1987. Effect of nandrolone therapy on forearm bone mineral content in osteoporosis. Clin Orthoped Rel Res 225: 273-278.
41. Need AG, et al.: 1989a. Effects of nandrolone decanoate and antiresorptive therapy on vertebral density in osteoporotic postmenopausal women. Arch Intern Med 149:57-60.
42. Need AG, et al: 1989b. Cross-over study of fat-corrected forearm mineral content during nandrolone decanoate therapy for osteoporosis. Bone 10:3-6.
43. Need AG, et al.: 1993. Double-blind placebo-controlled trial of treatment of osteoporosis with the anabolic nandrolone decanoate. Osteoporos Int (Suppl 1):S218-S222.
44. Nordin BEC, et al.: 1985. New approaches to the problems of osteoporosis. Clin Orthoped Rel Res 200:181-197.
45. Orwoll ES, Klein RF: 1995. Osteoporosis in men. Endocr Rev 16:87-116.
46. Orwoll ES, et al.: 1991. Androgen receptors in osteoblast-like cell lines. Calcif Tissue Int 49:182-187.
47. Passeri M, et al.: 1993. Effects of nandrolone decanoate on bone mass in established osteoporosis. Maturitas 17:211-219.
48. Smith EP, et al.: 1994. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 331:1056-1061.
49. Stepan JJ, Lachman M: 1989. Castrated men with bone loss: effect of calcitonin treatment on biochemical indices of bone remodeling. J Clin Endocrinol Metab 69:523-527.
50. Tenover JS: 1992. Effects of testosterone supplementation in the aging male. J Clin Endocrinol Metab 75:1092-1098.
51. Tenover JS: 1994. Androgen administration to aging men. Endocrinol Metab Clin North Am 23:877-892.
52. Turner RT, et al.: 1989. Differential effects of gonadal function in bone histomorphometry in male and female rats. J Bone Miner Res 4:557-563.
53. Turner RT, et al.: 1990. Differential effects of androgens on cortical bone histomorphometry in gonadectomized male and female rats. J Orthop Res 8:612-617.
54. Vanderschueren D, Bouillon R: 1995. Androgens and bone. Calcif Tissue Int 56:341-346.
55. Vanderschueren D, et al.: 1993. Bone and mineral metabolism in the androgen-resistant (testicular feminized) male rat. J Bone Miner Res 8:801-809.
56. Wakley GK, et al.: 1991. Androgen treatment prevents loss of cancellous bone in the orchidectomized rat. J Bone Miner Res 6: 325-330.